An oral weight-care option
Discuss an injection-free formulation for your goals. Injection trial results do not establish oral troche effectiveness.
← All treatments
NirvanixOral troche
Lean Balance
TirzepatidePackaging may vary. Compounded by a licensed pharmacy, not Nirvanix.
Weight care, with a clear plan
Lean Balance
GLP-1 Weight Loss – Tirzepatide (Troche)
An injection-free option for appetite and weight-management goals, in a small tablet that dissolves in your mouth.
Price pending
- Free shipping
Billing details
Shipping: Free. Final total confirmed before payment.
Shipping is included.
State availability is temporarily unavailable. Please check again before starting.
Loading the selected option…
Online enrollment for this option is being prepared. Existing patients can manage their care.
Frequently asked questions
Is this the same as an injectable tirzepatide product?
No. An oral troche uses a different route, and the cited injection studies do not establish its effectiveness or an equivalent dose.
Is this an FDA-approved oral tirzepatide medicine?
This compounded offering is not FDA-approved. Your clinician should explain its evidence and why it is being considered instead of approved alternatives.
Can I switch from injections using the same dose?
Do not convert doses yourself. Different routes are not interchangeable; discuss any change with your prescriber.
What should I ask before choosing a troche?
Ask what evidence supports this exact preparation, why it is being considered for you, and how it compares with approved options. Review the pharmacy's directions for using and storing the troche and the plan for checking your response.
What if I already take a weight-loss medicine?
Tell the clinician which medicine, dose, and schedule you use, when you last took it, and any side effects. That history is needed before considering a different preparation.
Where do I get my treatment instructions?
Your prescription and pharmacy label explain the exact amount, route, storage, and discard date. Ask your care team about anything unclear before starting; supply length is not a dosing instruction.
Safety information & side effects
Tirzepatide has important contraindications and side effects. Review these before starting.
- Do not use with a personal or family history of medullary thyroid cancer, MEN2, or a serious allergy to tirzepatide. Approved tirzepatide carries a boxed warning about thyroid C-cell tumors seen in animals; the risk in humans is unknown.
- Nausea, diarrhea, vomiting, constipation, and abdominal discomfort can occur. Severe or persistent abdominal pain, dehydration, or a serious allergic reaction needs urgent medical assessment.
- Discuss pancreatitis, gallbladder disease, severe stomach-emptying problems, kidney disease, and diabetic eye disease. Insulin and some diabetes medicines can increase low-blood-sugar risk.
- Do not use during pregnancy. Tirzepatide can affect oral contraceptive absorption; discuss additional or non-oral contraception and any planned anesthesia with your clinician. Do not combine with another tirzepatide or GLP-1 medicine unless specifically directed.
- Compounded medicines are not FDA-approved. Their safety, effectiveness, and quality have not been reviewed by FDA. Discuss approved alternatives and the exact preparation with your clinician.
This is a summary, not a complete prescribing guide. Read the information supplied with your prescription. For a severe allergic reaction or another medical emergency, call 911.
Sources & prescribing informationCompare other formulations & protocols
Different strengths, delivery methods, and combinations need their own clinical review.
Clinician reviewedPersonalized careOnline convenience
A closer look
Understand your options.
Start with what this treatment is, why it may be considered, and what to discuss with your clinician.
A dissolvable format
Use only the pharmacy's instructions for your prescribed troche; it is not a direct substitute for an injection dose.
A clinician-guided decision
Compare evidence, tolerability, and alternatives before deciding on a treatment approach.
How it works
The delivery method changes the question.
A troche dissolves in the mouth. Tirzepatide's major weight-loss trials used subcutaneous injections, so their absorption, dosing, and results cannot be assumed for an oral troche. The evidence for this specific preparation belongs at the center of your consultation.
Explore the evidenceYour timeline
Care that grows with your needs.
From your first assessment to follow-up, know what comes next. Your clinician sets the pace and the plan.
Complete an assessment covering your weight history, medications, health conditions, and goals.
A clinician assesses eligibility, formulation, alternatives, and any testing needed before a decision.
If prescribed, follow the exact pharmacy label and individual plan. Do not borrow a dosing schedule from another formulation.
Discuss progress and side effects at the follow-up interval set by your clinician. Dose changes depend on your response.
Care milestones are illustrative. Timing, testing, and treatment depend on your clinical review.
Personal care starts with context
Is it right for you?
A weight-care assessment looks beyond a number on the scale.
- Your weight-related health conditions and prior treatment experience.
- Your current medicines, digestive symptoms, and history of pancreatitis or gallbladder problems.
- Pregnancy plans and a personal or family history of medullary thyroid cancer or MEN2.
The evidence behind the conversation
Research & guidance.
Know what was studied, who took part, and how it relates to this option. Study findings are not a prediction of your results.
01SURMOUNT-1 · NEJM, 2022
Average weight reduction was 15.0%, 19.5%, and 20.9% with the three studied doses, compared with 3.1% with placebo.
- Treatment studied / guidance scope
- Subcutaneous tirzepatide 5, 10, or 15 mg weekly, with dose escalation and lifestyle support.
- Who it applies to
- 2,539 adults with obesity, or overweight with a weight-related condition, without diabetes.
- Timeframe
- 72 weeks
- Comparison
- Placebo plus lifestyle support
What this means for this optionThese results do not establish outcomes for low-dose regimens, oral troches, compounded preparations, or combinations with NAD+.
Read the source (opens in a new tab)02ZEPBOUND · Prescribing information
Approved injectable tirzepatide acts on GIP and GLP-1 receptors and has important contraindications and route-specific instructions.
- Treatment studied / guidance scope
- FDA-approved subcutaneous tirzepatide.
- Who it applies to
- Adults meeting the labeled indications.
- Timeframe
- Current prescribing information
- Comparison
- Not a trial of this offering
What this means for this optionApproval and dosing instructions for the branded injection do not apply automatically to a compounded preparation, oral troche, or combination.
Read the source (opens in a new tab)How we work
Your next chapter
starts with you.
Tell us about yourself
Choose a treatment and complete its assessment when enrollment is available.
Connect with a clinician
Review your options, including any labs or video visit needed for a decision.
Follow your personal plan
If prescribed, begin treatment and stay connected through your patient portal.
Nirvanix Health
Personal care.
Part of your everyday.
The people behind Nirvanix
Your health deserves a thoughtful conversation.
Our founder, Shane Ali, MD, is a board-certified emergency medicine physician. Meet the Nirvanix team and learn about our approach to care.
Meet the teamYour online clinician is assigned according to your treatment and state.
A little more clarity
Your questions, answered.
Comparing costs or getting ready to start? Read our care FAQs.
Have a question about your own care? Sign in to your account.
Is this the same as an injectable tirzepatide product?
No. An oral troche uses a different route, and the cited injection studies do not establish its effectiveness or an equivalent dose.
Is this an FDA-approved oral tirzepatide medicine?
This compounded offering is not FDA-approved. Your clinician should explain its evidence and why it is being considered instead of approved alternatives.
Can I switch from injections using the same dose?
Do not convert doses yourself. Different routes are not interchangeable; discuss any change with your prescriber.
What should I ask before choosing a troche?
Ask what evidence supports this exact preparation, why it is being considered for you, and how it compares with approved options. Review the pharmacy's directions for using and storing the troche and the plan for checking your response.
What if I already take a weight-loss medicine?
Tell the clinician which medicine, dose, and schedule you use, when you last took it, and any side effects. That history is needed before considering a different preparation.
Where do I get my treatment instructions?
Your prescription and pharmacy label explain the exact amount, route, storage, and discard date. Ask your care team about anything unclear before starting; supply length is not a dosing instruction.
Your goals. Your next chapter.
Let’s make your care personal.
Start with your history and a conversation about what matters to you.
State availability is temporarily unavailable. Please check again before starting.
Prefer an in-person visit? Explore our Austin clinic.